Clinical Trial Update: Expanded Access for Treatment With Imetelstat

View source ↗

Summary

Expanded access update for imetelstat in myelodysplastic syndromes with status listed as approved for marketing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Geron Corporation | Conditions: Myelodysplastic Syndromes | Status: APPROVED_FOR_MARKETING